Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

NBS:US

2.8800 USD 0.0700 2.37%

As of 20:10:00 ET on 05/22/2015.

Snapshot for NeoStem Inc (NBS)

Open: 3.0700 Day's Range: 2.6600 - 3.1500 Volume: 3,510,210
Previous Close: 2.9500 52wk Range: 2.1500 - 7.2300 1-Yr Rtn: -52.32%

Stock Chart for NBS

No chart data available.
  • NBS:US 2.8604
  • 1D
  • 1M
  • 1Y
2.9500
Interactive NBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBS

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.7445
Est. EPS (USD) (12/2015) -1.6820
Est. PEG Ratio -
Market Cap (M USD) 115.64
Shares Outstanding (M) 40.15
30 Day Average Volume 643,140
Price/Book (mrq) 2.2526
Price/Sale (ttm) 5.7101
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBS

NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.

Robin L SmithChairmanDavid J MazzoChief Executive Officer
Robert S VatersPresident/CFOAndrew L PecoraChief Visionary Officer
More Company Profile & Key Executives for NBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil